Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock

About this update from Mesa Laboratories, Inc.

[{"type":"text","content":"Source: Mesa Laboratories, Inc. - June 9, 2020 8:15 PM ET\n Lakewood, Colo., June 09, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced the pricing of an underwritten public offering of 600,000 shares of its common stock at a public offering price of $225.00 per share for gross proceeds of approximately $135 million before deducting underwriting discounts and commissions and other estimated offering expenses. In addition, Mesa Labs has granted the underwriters a 30-day option to purchase up to 90,000 additional shares. The offering is expected to settle on June 12, 2020, subject to customary closing conditions. Mesa Labs intends to use the net proceeds from the offering for general corporate purposes, which may include acquisitions. Jefferies LLC, J.P. Morgan and Evercore Group L.L.C. are acting as joint book-running managers for the offering. The offering is being made pursuant to Mesa Labs’ shelf registration statement (including a base prospectus) and a preliminary prospectus supplement (together with such base prospectus, the “prospectus”), all of which Mesa Labs filed with the Securities and Exchange Commission (the “SEC”). Mesa Labs will file with the SEC the final prospectus supplement related to the offering. Before investing in Mesa Labs’ common stock, investors should read the prospectus, including the documents incorporated by reference therein, and any free writing prospectus related to the offering. These documents may be freely obtained by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies may be obtained, when available, from Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at (877) 821-7388, or by email at [email protected], or from J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204, or by email at [email protected], or from Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, NY 10055, or by telephone at (888) 474-0200, or by email at [email protected]. This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any offer or sale ...

More updates from Mesa Laboratories, Inc.